BerGenBio ASA: Increase of share capital, exercise of share options
Bergen, Norway, 23 August 2021 The Board of Directors in BerGenBio ASA (the "Company") (OSE: BGBIO) have, to fulfil the Company's obligations under the share option agreements and in accordance with the authorization granted by the general meeting on 19 March 2021, resolved to increase the Company's share capital by NOK 27,000 by issuance of 270,000 new shares. The new shares are subscribed for by option owners who wishes and are entitled to exercise options in accordance with the Company's option scheme. Each option gives a right to receive one share in the Company. The subscription